Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up
Table 5
Uni- and multivariate logistic regression analyses for MRproADM levels at ICU admission to predict ICU and overall mortality.
Parameter
ICU mortality
Overall mortality
Unadjusted OR (95% CI)
Adjusted OR (95% CI)
Unadjusted OR (95% CI)
Adjusted OR (95% CI)
3.7 (1.47-9.29)
0.005
3.15 (1.08-9.20)
0.036
2.8 (1.44-5.55)
0.003
2.4 (1.12-5.34)
0.026
Lactate
1.159 (1.01-1.33)
0.040
1.20 (1.01-144)
0.043
1.19 (1.02-1.39)
0.027
1.25 (1.04-1-51)
0.016
Age
1.04 (1.01-1.06)
0.004
1.03 (0.99-1-06)
n.s.
1.04 (1.01-1.06)
0.001
1.03 (1.00-1-05)
n.s.
APACHE II
1.09 (1.04-1.14)
<0.001
1.06 (1.01-1.12)
0.014
1.06 (1.02-1.10)
0.004
1.03 (0.99-1-08)
n.s.
Abbreviations: 95% CI: 95% confidence interval; APACHE II: acute physiology and chronic health evaluation; MRproADM: midregional proadrenomedullin; OR: odds ratio.
